期刊文献+

寡聚脱氧核苷酸的结构与抗降解特性的研究 被引量:1

A Study on the Stability of Oligodeoxyribonucleotides with Different Structure and Modification
下载PDF
导出
摘要 合成了4段具有不同高级结构或不同修饰的寡聚脱氧核苷酸,检查它们在20%血清中的稳定性.发现:(1)寡核苷酸主要被血清中的3′外切核酸酶降解,未经修饰的线性寡核苷酸降解严重;(2)末端部分硫代修饰的寡核苷酸稳定性明显提高;(3)自身互补形成的配对结构可有效保护3′末端.具有4个以上(含4个)GC对的3′端发夹结构寡核苷酸,其抗核酸酶的能力几乎与硫代修饰的寡核苷酸相当. The stabilities of four oligodeoxyribonucleotides(ODN) with different secondary structure and different modification in 20% human serum were studied.The experiment demonstrated that:1).3' exonuclease is primarily responsible for the degradation of ODN in serum,most of the unmodified linear ODN is seriously degraded in serum;2).ODN containing three phosphorothioate bonds in its 3' and 5'ends have increased nuclease resistance obviously;3).3' end self complementary ODNs with a hairpin loop structure have protected the 3'end from nuclease effectively,ability of nuclease resistance of ODN containing more than four CG pairs in hairpin loop of 3' end almost equal to its partial phosphorothioated component.
作者 董凡 金由辛
出处 《中国生物化学与分子生物学报》 CAS CSCD 1998年第1期62-64,共3页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家"八六三"高科技项目 上海市科委资助 国家自然科学基金
关键词 寡聚脱氧核苷酸 二级结构 抗降解特性 Oligodeoxyribonucleotide,Secondary sructure,Nuclease resistance
  • 相关文献

参考文献3

二级参考文献1

  • 1裘慕绥,中国科学.B,1991年,6期,602页

同被引文献21

  • 1Kovarik J, Bozzotti P, Love-Homan L, et al. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but fail to fully redirect Th2 responses established by neonatal priming. J Immunol, 1999, 162(8): 1611-1617.
  • 2Elen T, Takabayashi K J, Takabayashi K, Schwartz D, et al.Conjugation of protein to immunostimulatory DNA results in a rapid, ling-lasting and potent induction of cell-mediated and humoral immunity. Eur J Immunol, 2000, 30 (5): 1939-1947.
  • 3Hartmann G, Krieg A M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol,2000, 164 (3): 944-952.
  • 4Hartmann G, Risini D. Delineation of a CpG phophorothioate oligodeoxynucleotide for activating primate immune response in vitor and invivo. J Immunology, 2000, 164 (4): 1617--1624.
  • 5Wernette C M, Smith B F, Barksdale Z L, et al.CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation. Veterinary Immunology and Immunopathology,2002, 84 (3): 223--236.
  • 6Pontarollo R A, Rankin R, Babiuk L A, et al. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet Immunol Immunopathol, 2002, 84 (1): 43~59.
  • 7KriegA M, Yi A K, Schorr J, et al. The role of CpG denucleotides in DNA vaccine. Trends Microbiol, 1998, 6 (1) :23 ~ 27.
  • 8Rankin R, Pontarollo R, Gomis S, et al. CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine, 2002, 20(23) : 3014--3022.
  • 9Chu R S, Askew D, Noss E H, et al. CpG oligodeoxynucleotides sown-regulate macrophage class Ⅱ MHC antigen processing. J Immunol, 1999, 163 (3): 1188-1194.
  • 10IhoS, Yamamoto T, Takahashi T, et al. Oligodeoxynudeotides containing palindrome sequences with internal 5'-CpG-3" act directly on human NK and activated T cell to induce INF-γ production in vitro. J Immunol, 1999, 163 (4): 3642-3652.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部